Citigroup’s Globus Medical GMED Stock Holding History

Citigroup’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-75,000	Closed	-$2.23M	–	7585
2017 Q3	$2.23M	Buy	+75,000	New	+$2.29M	﹤0.01%	2542

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's GMED Position: Q1 2026 in Review

Citigroup reduced its Globus Medical (GMED) stake by 23% in Q1 2026, selling an estimated $815K and leaving 30,573 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Citigroup first reported a position in GMED in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.61M in Q1 2021. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Citigroup held 30,573 shares of Globus Medical worth $2.63M as of Q1 2026.
Citigroup sold 9,084 Globus Medical shares in Q1 2026, an estimated $815K.
Globus Medical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2494 holding.
Citigroup first reported a position in Globus Medical in Q2 2013 and has held it in 52 quarters since.
Citigroup's Globus Medical position peaked at $7.61M in Q1 2021.
603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.